This contrasts with the broader hematopoietic defects caused by METTL3 loss.36, 37, 38 In hepatocellular carcinoma, METTL3 is frequently overexpressed and oncogenic, and METTL14 is often down-regulated and acts as a tumor suppressor.39 This evidence concerns the gene METTL3 and hepatocellular carcinoma.